Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
R03AK10 Vilanterol and fluticasone furoate
D10501 Fluticasone furoate and vilanterol trifenatate <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Bronchodilator Combinations
Fluticasone Furoate/ Vilanterol Trifenatate
D10501 Fluticasone furoate and vilanterol trifenatate
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
229 Miscellaneous
2290 Miscellaneous
D10501 Fluticasone furoate and vilanterol trifenatate
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D10501 Fluticasone furoate and vilanterol trifenatate
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10501
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10501
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10501
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10501
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10501
